Reaction Details |
| Report a problem with these data |
Target | Galectin-1 |
---|
Ligand | BDBM653577 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Evaluation of Kd Values |
---|
Kd | 9.00±n/a nM |
---|
Citation | PETERSON, K; ZETTERBERG, F; NILSSON, U NOVEL GALACTOSIDE INHIBITOR OF GALECTINS US Patent US20240059728 Publication Date 2/22/2024 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Galectin-1 |
---|
Name: | Galectin-1 |
Synonyms: | 14 kDa lectin | Galaptin | HPL | LEG1_HUMAN | LGALS1 | Lactose-binding lectin 1 | Lectin galactoside-binding soluble 1 | Putative MAPK-activating protein PM12 |
Type: | beta galactoside-binding protein |
Mol. Mass.: | 14713.53 |
Organism: | Homo sapiens (Human) |
Description: | P09382 |
Residue: | 135 |
Sequence: | MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIV
CNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINY
MAADGDFKIKCVAFD
|
|
|
BDBM653577 |
---|
n/a |
---|
Name | BDBM653577 |
Synonyms: | 3′-[4-(2-Aminothiazol-4-yl)-1H-1,2,3-triazol-1-yl]-3-[4-(4-chloro-3,5-difluorophenyl)-1H-1,2,3-triazol-1-yl]-3,3′-dideoxy-1,1′-sulfanediyl-di-β-D-galactopyranoside | US20240059728, Example 3 |
Type | Small organic molecule |
Emp. Form. | C25H27ClF2N8O8S2 |
Mol. Mass. | 705.11 |
SMILES | Nc1nc(cs1)-c1cn(nn1)C1C(O)[C@@H](CO)O[C@@H](S[C@@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(Cl)c(F)c2)[C@@H]1O |r| |
Structure |
|